FDA
approval
· 2021-03-04
FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Butorphanol Tartrate from Hikma Pharmaceuticals USA Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)